Phase II Study of PG-102(MG12) Compared With Placebo in Obesity and Type 2 Diabetes

Clinical trial NCT06712615 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06712615
Sponsor: ProGen. Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus (T2DM)Obesity Type 2 Diabetes Mellitus

Start date: 2024-12-05
Primary completion: 2025-10-30
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.